We are a team on a mission‚Äč

Stratipath brings together clinicians, researchers, AI scientists, developers and industry specialists on its mission to provide every patient with the right treatment at the right time.

Stratipath’s novel solutions are driven by a rigorous scientific development process based on state-of-the-art machine- and deep-learning methods. By providing fast, accessible, and cost-effective precision diagnostics, we aim to minimise over- and undertreatment and reduce healthcare costs, benefiting all of society.

Stratipath brings together clinicians, researchers, AI scientists, developers and industry specialists on its mission to provide every patient with the right treatment at the right time.

Stratipath’s novel solutions are driven by a rigorous scientific development process based on state-of-the-art machine- and deep learning methods. By providing fast, accessible, and cost-effective precision diagnostics, we aim to minimise over- and undertreatment, and reduce healthcare costs, benefiting all of society.

Stratipath at a glance:

First-in-class solution

A paradigm shift in prognostic risk stratification of breast cancer, providing an alternative to expensive and time-consuming molecular assays.

Strong partnerships

For commercial rollout, distribution and optimal clinical workflow. SaaS solution integrated with leading digital pathology solutions.

Ongoing clinical implementation

In healthcare – oncology clinics and pathology labs.

AI platform & unique data

AI platform enabling rapid development, validation and deployment of AI-based precision diagnostics.

Clinical evidence

Published in high-impact journals and ongoing studies to support current and future solutions.

First-in-class solutions

A paradigm shift in prognostic risk stratification of breast cancer, providing an alternative to expensive and time-consuming molecular assays.

Strong partnerships

For commercial rollout, distribution and optimal clinical workflow. SaaS solution integrated with leading digital pathology solutions.

Ongoing clinical implementation

In healthcare – oncology clinics and pathology labs.

AI platform & unique data

AI platform enabling rapid development, validation and deployment of AI-based precision diagnostics.

Clinical evidence

Published in high-impact journals and ongoing studies to support current and future solutions.

Our vision:

The right treatment for every patient

Stratipath aims to enable precision medicine by providing novel prognostic and predictive information. By reducing the number of patients assigned to intermediate-risk groups in diagnostic pathology, Stratipath provides support for clinicians in their therapeutic decision-making. We also offer pharma and biotech companies an accelerated path to patient stratification by identifying biomarker strategies and subgroups of patients that may benefit from specific therapies.

Sustainable healthcare

By providing fast, accessible, and cost-effective precision diagnostics, we aim to minimise over- and undertreatment, and reduce healthcare costs, benefiting all of society.

Equal care

Stratipath develops effective and cost-efficient decision support tools to allow faster and more reproducible results with reduced risk of diagnostic errors. This contributes to a greater equality of care for all patients.

The Stratipath team:

Johan Hartman

Chief Medical Officer, CO-FOUNDER, MD, PhD, Professor Karolinska Institutet

Johnson Ho

Solution architect & AI Engineer, PhD

Emma Jansson

Quality assurance manager, MSc

Annica Jämtén Ericsson

Chief Operation Officer, MSc

Sandy Kang Lövgren

AI Engineer, BSc

Emelie Karlsson

Customer Service Specialist, BSc

Kajsa Ledesma Eriksson

AI Engineer, MSc

Lars Lengquist

Head of communication & design

Jennie Ousbäck

Head of Regulatory affairs and Quality assurance, MSc

Mattias Rantalainen

Chief Technology Officer, CO-FOUNDER, PhD, Associate Professor Karolinska Institutet

Stephanie Robertson

Medical Manager, MD, PhD

Lars Sjögreen

Engineering Manager, Foundation Services

Binbin Su

AI Scientist, PhD, MSc

Yinxi Wang

AI Scientist, MD, PhD

Philippe Weitz

Senior AI Scientist, PhD, MsC

Fredrik Wetterhall

Chief Executive Officer, CO-FOUNDER

Board and advisors:

Additional board members are Stratipath co-founders Johan Hartman, Mattias Rantalainen and Fredrik Wetterhall.

Jonas Bergh

Head of Advisory board | MD, PhD, Professor of Oncology, Karolinska Institutet

Carl Rahmström

Board Member

Erik Gozzi

Board Member